                               SEQUENCE LISTING

<110> THE GENERAL HOSPITAL CORPORATION
 
<120> ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF

<130> 29539-0413WO1

<140> PCT/US2020/041971
<141> 2020-07-14

<150> 62/874,075
<151> 2019-07-15

<160> 36    

<170> PatentIn version 3.5

<210> 1
<211> 33
<212> DNA
<213> Danio rerio

<400> 1
tgcatataca gaaccgtatc aagcgcgggg ggt                                    33


<210> 2
<211> 27
<212> DNA
<213> Danio rerio

<400> 2
taggcccttg actacatatg gtgaggt                                           27


<210> 3
<211> 33
<212> DNA
<213> Danio rerio

<400> 3
accccccgcg cttgatacgg ttctgtatat gca                                    33


<210> 4
<211> 27
<212> DNA
<213> Danio rerio

<400> 4
acctcaccat atgtagtcaa gggccta                                           27


<210> 5
<211> 27
<212> DNA
<213> Danio rerio

<400> 5
tggttctggc attatctgta gtggaaa                                           27


<210> 6
<211> 28
<212> DNA
<213> Danio rerio

<400> 6
ggtccgtcgt cgttcatcag ctcgtcga                                          28


<210> 7
<211> 27
<212> DNA
<213> Danio rerio

<400> 7
tttccactac agataatgcc agaacca                                           27


<210> 8
<211> 28
<212> DNA
<213> Danio rerio

<400> 8
tcgacgagct gatgaacgac gacggacc                                          28


<210> 9
<211> 53
<212> DNA
<213> Danio rerio

<400> 9
tgtgcagtgt aaaatcatca acgtggacta tgtggagtgc atctggcaac gga              53


<210> 10
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
tgtgcagtgt aaaatcatca acgtgtggag tgcatctggc aacgga                      46


<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 11
agaaccgtat caagcgcggg                                                   20


<210> 12
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
ggcccttgac tacatatggt g                                                 21


<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 13
ggttctggca ttatctgtag                                                   20


<210> 14
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 14
agcagcaagt agtcgagcag                                                   20


<210> 15
<211> 18
<212> DNA
<213> Danio rerio

<400> 15
tacattgaaa acaagcct                                                     18


<210> 16
<211> 20
<212> DNA
<213> Danio rerio

<400> 16
agtttggtga cggaacagga                                                   20


<210> 17
<211> 18
<212> DNA
<213> Danio rerio

<400> 17
tgygcagtgt aaaatcat                                                     18


<210> 18
<211> 18
<212> DNA
<213> Danio rerio

<400> 18
agtgcatctg gcaacgga                                                     18


<210> 19
<211> 13
<212> DNA
<213> Danio rerio

<400> 19
gactgaattg ctt                                                          13


<210> 20
<211> 19
<212> DNA
<213> Danio rerio

<400> 20
aagatttggg tcttacaga                                                    19


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ala Val Ser Arg Leu Arg Ala Tyr 
1               5               


<210> 22
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Ala Pro Pro Pro Val Val Leu Leu 
1               5               


<210> 23
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Ser Gly Arg Ser Ala 
1               5   


<210> 24
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Pro Arg Cys Phe Phe Arg Leu Gly Lys 
1               5                   


<210> 25
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
His Pro Val Gly Leu Leu Ala Arg 
1               5               


<210> 26
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Pro Arg Gly Leu Arg Lys 
1               5       


<210> 27
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Gly Pro Leu Pro Leu Arg 
1               5       


<210> 28
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Ala Ile Pro Val Ser Leu Arg 
1               5           


<210> 29
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Gly Pro Leu Gly Val Arg Gly Lys 
1               5               


<210> 30
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Pro Arg His Leu Arg 
1               5   


<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Gly Pro Gln Gly Ile Ala Gly Gln Arg 
1               5                   


<210> 32
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Gly Lys Ala Phe Arg Arg Leu 
1               5           


<210> 33
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Pro Arg Ala Leu Met 
1               5   


<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Asp Ile Lys Asp Ile Val Gly Pro 
1               5               


<210> 35
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Asn Pro Tyr Arg Tyr Thr Glu Ile 
1               5               


<210> 36
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Ser Ser Arg Asp Leu Leu Gly 
1               5               


